COMMUNIQUÉS West-GlobeNewswire

Agios Announces First Patient Dosed with MAT2A Inhibitor AG-270 in Phase 1 Study in Patients with Advanced Solid Tumors or Lymphoma with an MTAP Deletion
19/03/2018
CAMBRIDGE, Mass., March 19, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO ), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced dosing of the [...]
Pain Therapeutics Announces FDA Advisory Committee Meeting for REMOXY ER®
19/03/2018
AUSTIN, Texas, March 19, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE ), a drug development company, announced today that the U.S. Food and Drug Administration (FDA) will hold an Advisory Committee [...]
Axsome Therapeutics to Present at 17th Annual Needham Healthcare Conference
19/03/2018
NEW YORK, March 19, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM ), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders [...]
The AdVance Study: a Landmark Natural History Study of Adenovirus in Allogeneic Hematopoietic Cell Transplant Shows Strong Correlation Between Disease Burden and Mortality Risk
19/03/2018
DURHAM, N.C., March 19, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX ), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced data from AdVance, the first large, [...]
Motif Bio to present at upcoming investor and scientific conferences
19/03/2018
NEW YORK, March 19, 2018 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM:MTFB) (NASDAQ: MTFB ), a clinical stage biopharmaceutical company specialising in developing novel antibiotics, announces that the Company will present at [...]
VALNEVA Reports Positive Phase I Interim Results for Its Lyme Vaccine Candidate VLA15
19/03/2018
Valneva Reports Positive Phase I Interim Results for Its Lyme Vaccine Candidate VLA15 Phase I study (VLA15-101) primary endpoint met No safety concerns associated with VLA15 in any treatment group Encouraging [...]
VALNEVA publie des résultats intermédiaires de Phase I positifs pour son candidat vaccin contre la maladie de Lyme VLA15
19/03/2018
Valneva publie des résultats intermédiaires de Phase I positifs pour son candidat vaccin contre la maladie de Lyme VLA15 Critère d'évaluation principal de l'étude de Phase I (VLA15-101) atteint Aucun problème de [...]
MDxHealth (R): SelectMDx Liquid Biopsy Test for Prostate Cancer included in the 2018 European Association Urology Guidelines
19/03/2018
NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION A significant milestone in MDxHealth's strategy to increase adoption of SelectMDx ® HERSTAL, BELGIUM and IRVINE, CA - 07:00 CEST, March 19, 2018 - MDxHealth SA ( [...]
MDxHealth (R) : Le test de biopsie liquide SelectMDx® pour le cancer de la prostate est inclus dans les directives 2018 de l'Association Européenne d'Urologie
19/03/2018
COMMUNIQUÉ DE PRESSE INFORMATION RÉGLEMENTÉE INFORMATION PRIVILEGIEE Une étape clé dans la stratégie de MDxHealth visant à accroître l'utilisation de SelectMDx HERSTAL, BELGIQUE et IRVINE, CA - 07 :00 CEST, le 19 mars [...]
Addex Shareholders Approved all Board Proposals at Extraordinary General Meeting
19/03/2018
Geneva, Switzerland, 19 March 2018 - Addex Therapeutics (SIX: ADXN), the leading developer of oral allosteric modulators for neurological disorders, announced today that its shareholders approved all the proposals of [...]
Idorsia issues invitation to 2018 Annual General Meeting of Shareholders
19/03/2018
Allschwil, Switzerland - March 19, 2018 - Idorsia Ltd (SIX: IDIA) today issued the formal invitation to the upcoming Annual General Meeting (AGM) of Shareholders on behalf of the Board of Directors. The meeting to [...]
Strongbridge Biopharma plc Announces Presentation of New Data Demonstrating That Levoketoconazole is a Potent Inhibitor of Human Enzymes Controlling Cortisol Synthesis
18/03/2018
~ Data Suggest Levoketoconazole, the Isolated 2S,4R Enantiomer of Ketoconazole, Accounts for Essentially All of the Inhibition by Ketoconazole of Cortisol Biosynthesis in Humans ~ ~ Results Presented at ENDO 2018, the [...]
Radius Health Presents Positive Data for the ACTIVExtend BMD Responder Analysis for TYMLOS™ (abaloparatide) Injection at ENDO 2018 Annual Meeting
17/03/2018
WALTHAM, Mass., March 17, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS ), a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative [...]
Abeona Therapeutics Reports Fourth Quarter 2017 Financial Results and Business Highlights
16/03/2018
NEW YORK and CLEVELAND, March 16, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ: ABEO ), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life- [...]
Matinas BioPharma Appoints Jerome D. Jabbour as Chief Executive Officer and Provides Corporate Update
16/03/2018
Leadership appointment positions Company for next stage of value creation Successful outcome of meeting with FDA provided important insight and clarity for clinical development path forward for MAT2203 Conference call [...]
DBV Technologies Announces Filing of 2017 "Document de Référence" and 2017 Annual Report on Form 20-F
16/03/2018
Montrouge, France, March 16, 2018 DBV Technologies Announces Filing of 2017 "Document de Référence" and 2017 Annual Report on Form 20-F DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) [...]
DBV Technologies Publie son Document de Référence 2017 et son «Form 20-F» américain
16/03/2018
Montrouge, France, le 16 mars, 2018 (21:30 CET) DBV Technologies Publie son Document de Référence 2017 et son «Form 20-F» américain DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq : DBVT), une société [...]
Reata Selected to Present Early-Stage Programs at the BIO Asia International Conference
16/03/2018
IRVING, Texas, March 16, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA ) (Reata or Company), a clinical-stage biopharmaceutical company, today announced that Chief Development Officer, Keith Ward, [...]
Geron Corporation Reports Fourth Quarter and Annual 2017 Financial Results and Recent Events
16/03/2018
MENLO PARK, Calif., March 16, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN ) today reported financial results for the fourth quarter and year ended December 31, 2017 and recent events. Fourth Quarter and [...]

Pages